Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tagatose SCHEMBL5699125 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL37179 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL2123235 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL16944031 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Tagatose SCHEMBL4035 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Tagatose SCHEMBL23827342 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Tagatose SCHEMBL21816881 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL20898472 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL21114385 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL9581175 | 1.00 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 917 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120400260-B | Hydrogen production reaction system and hydrogen production method using formaldehyde and water as cosubstrates | Westlake University (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-3262179-B1 | ELECTROCHEMICAL BIOREACTOR MODULE AND ENGINEERED METABOLIC PATHWAYS FOR 1- BUTANOL PRODUCTION WITH HIGH CARBON EFFICIENCY | BIOCHEMINSIGHTS INC (US) | 2026-04-29 | — | — | EP | claimed |
| EP-3881826-B1 | NATURAL NOSE AND THROAT SPRAY | MULTIOSSIGEN S P A (IT) | 2026-04-22 | — | — | EP | claimed |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | AGAIN BIO APS (DK) | 2026-02-05 | — | — | US | claimed |
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | GENOMATICA, INC. (US) | 2026-01-20 | — | — | US | claimed |
| US-20250332079-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2025-10-30 | — | — | US | claimed |
| CN-120082612-A | Method for preparing D-type rare hexulose by metabolic engineering modification of bacillus subtilis | 江南大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119924404-A | Beautifying sugar-free gel candy and preparation method and application thereof | 吉林修正健康股份有限公司天津研发分公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119876297-A | Method for efficiently producing D-type rare hexulose in bacillus subtilis | 江南大学 | 2025-04-25 | — | — | CN | claimed |
| EP-4529566-A1 | NOVEL CARBON FIXATION PATHWAY | The Regents of the University of California (US) | 2025-04-02 | — | — | EP | claimed |
| CN-111088301-B | Preparation method of L-type rare hexulose | 江南大学 | 2022-05-03 | — | — | CN | claimed |
| CN-216303798-U | Enzyme reaction device that rose natural pigment drawed | 文山玖香鲜花生物科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-111808690-B | Foam enhancing saccharide blends | 西南沿岸有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-114207121-A | Methanol utilization | 银杏生物制品公司 | 2022-03-18 | — | — | CN | claimed |
| EP-3956441-A1 | METHANOL UTILIZATION | Ginkgo Bioworks, Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| WO-2022026960-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC | 2021-11-25 | — | — | US | claimed |
| US-20210251260-A1 | METHANOIC ACID COMPOSITION AND ITS USES THEREOF | K RITHVIK (IN) | 2021-08-19 | — | — | US | claimed |
| WO-2021158714-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158574-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529078-B2 | Microorganisms and methods for improving product yields on methanol using acetyl-CoA synthesis | ALDOA, FDPS, DERA | CYP2C9 1687/4885TSHR 4558/4885PDE4A 1656/4885 |
| US-20250332079-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | CYP2C9 230/4885TSHR 4612/4885PDE4A 4697/4885 |
| US-20260035705-A1 | ENGINEERED MICROORGANISMS WITH G3P ->3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | ME1, FBP1, ME3 | CYP2C9 1020/4885TSHR 4000/4885PDE4A 1789/4885 |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | CNR2, CNR1, FAAH | CYP2C9 578/4885TSHR 4477/4885PDE4A 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.